Status
Conditions
Treatments
About
The prospective BoHemE study is designed to evaluate the correlation between bone marrow function and skeletal health in elderly patients (>= 60 years) with or without pre-existing myelodysplastic syndromes (MDS).
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria Group 1 (MDS group):
Inclusion Criteria Group 2 (control group):
Exclusion Criteria Group 1 (MDS group) + 2 (control group):
297 participants in 2 patient groups
Loading...
Central trial contact
Anna Mies, PhD; Uwe Platzbecker, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal